HealthEquity (HQY) Competitors

$81.65 -3.19 (-3.76%)

Closing price 04:00 PM Eastern

Extended Trading

$83.84 +2.18 (+2.68%)

As of 05:42 PM Eastern

HQY vs. ITGR, IQV, FTAI, AER, and CPAY

Should you be buying HealthEquity stock or one of its competitors? The main competitors of HealthEquity include Integer (ITGR), IQVIA (IQV), FTAI Aviation (FTAI), Aercap (AER), and Corpay (CPAY).

How does HealthEquity compare to Integer?

HealthEquity (NASDAQ:HQY) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

HealthEquity has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19
Integer	$1.85B	1.56	$102.81M	$4.01	21.17

In the previous week, HealthEquity had 1 more articles in the media than Integer. MarketBeat recorded 10 mentions for HealthEquity and 9 mentions for Integer. HealthEquity's average media sentiment score of 1.33 beat Integer's score of 1.10 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity presently has a consensus price target of $111.79, indicating a potential upside of 36.91%. Integer has a consensus price target of $98.29, indicating a potential upside of 15.77%. Given HealthEquity's stronger consensus rating and higher possible upside, equities analysts plainly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

HealthEquity has a net margin of 16.39% compared to Integer's net margin of 7.64%. HealthEquity's return on equity of 13.86% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	16.39%	13.86%	8.67%
Integer	7.64%	12.83%	6.51%

HealthEquity has a beta of 0.19, suggesting that its share price is 81% less volatile than the broader market. Comparatively, Integer has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

HealthEquity beats Integer on 14 of the 17 factors compared between the two stocks.

How does HealthEquity compare to IQVIA?

IQVIA (NYSE:IQV) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

IQVIA has higher revenue and earnings than HealthEquity. IQVIA is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.31B	1.78	$1.36B	$8.07	21.50
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19

In the previous week, IQVIA had 19 more articles in the media than HealthEquity. MarketBeat recorded 29 mentions for IQVIA and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.33 beat IQVIA's score of 0.93 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	13 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IQVIA has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, suggesting that its share price is 81% less volatile than the broader market.

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.7% of IQVIA shares are owned by company insiders. Comparatively, 1.5% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

HealthEquity has a net margin of 16.39% compared to IQVIA's net margin of 8.33%. IQVIA's return on equity of 30.50% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.33%	30.50%	6.53%
HealthEquity	16.39%	13.86%	8.67%

IQVIA currently has a consensus price target of $225.69, indicating a potential upside of 30.06%. HealthEquity has a consensus price target of $111.79, indicating a potential upside of 36.91%. Given HealthEquity's higher possible upside, analysts clearly believe HealthEquity is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	3.00
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

Summary

IQVIA beats HealthEquity on 10 of the 17 factors compared between the two stocks.

How does HealthEquity compare to FTAI Aviation?

FTAI Aviation (NASDAQ:FTAI) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

FTAI Aviation has a net margin of 18.92% compared to HealthEquity's net margin of 16.39%. FTAI Aviation's return on equity of 181.43% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FTAI Aviation	18.92%	181.43%	12.45%
HealthEquity	16.39%	13.86%	8.67%

FTAI Aviation has higher revenue and earnings than HealthEquity. HealthEquity is trading at a lower price-to-earnings ratio than FTAI Aviation, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FTAI Aviation	$2.51B	11.47	$501.06M	$5.04	55.63
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19

89.0% of FTAI Aviation shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.4% of FTAI Aviation shares are owned by company insiders. Comparatively, 1.5% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

FTAI Aviation currently has a consensus target price of $326.88, indicating a potential upside of 16.59%. HealthEquity has a consensus target price of $111.79, indicating a potential upside of 36.91%. Given HealthEquity's higher probable upside, analysts clearly believe HealthEquity is more favorable than FTAI Aviation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FTAI Aviation	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

In the previous week, FTAI Aviation had 9 more articles in the media than HealthEquity. MarketBeat recorded 19 mentions for FTAI Aviation and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.33 beat FTAI Aviation's score of 0.73 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FTAI Aviation	10 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

FTAI Aviation has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, suggesting that its share price is 81% less volatile than the broader market.

Summary

FTAI Aviation beats HealthEquity on 11 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Aercap?

Aercap (NYSE:AER) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Aercap presently has a consensus target price of $163.13, suggesting a potential upside of 11.63%. HealthEquity has a consensus target price of $111.79, suggesting a potential upside of 36.91%. Given HealthEquity's higher possible upside, analysts clearly believe HealthEquity is more favorable than Aercap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aercap	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.10
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

In the previous week, HealthEquity had 4 more articles in the media than Aercap. MarketBeat recorded 10 mentions for HealthEquity and 6 mentions for Aercap. Aercap's average media sentiment score of 1.33 beat HealthEquity's score of 1.33 indicating that Aercap is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aercap	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.4% of Aercap shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.5% of Aercap shares are held by company insiders. Comparatively, 1.5% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aercap has higher revenue and earnings than HealthEquity. Aercap is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aercap	$8.52B	2.86	$3.75B	$22.82	6.40
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19

Aercap has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market.

Aercap has a net margin of 45.22% compared to HealthEquity's net margin of 16.39%. Aercap's return on equity of 16.01% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aercap	45.22%	16.01%	4.04%
HealthEquity	16.39%	13.86%	8.67%

Summary

Aercap beats HealthEquity on 9 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Corpay?

HealthEquity (NASDAQ:HQY) and Corpay (NYSE:CPAY) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Corpay has a net margin of 24.60% compared to HealthEquity's net margin of 16.39%. Corpay's return on equity of 38.68% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	16.39%	13.86%	8.67%
Corpay	24.60%	38.68%	6.46%

In the previous week, Corpay had 15 more articles in the media than HealthEquity. MarketBeat recorded 25 mentions for Corpay and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.33 beat Corpay's score of 0.71 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Corpay	7 Very Positive mention(s)	1 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 98.8% of Corpay shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 5.2% of Corpay shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Corpay has higher revenue and earnings than HealthEquity. Corpay is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19
Corpay	$4.53B	5.14	$1.07B	$16.71	20.46

HealthEquity currently has a consensus target price of $111.79, suggesting a potential upside of 36.91%. Corpay has a consensus target price of $375.58, suggesting a potential upside of 9.86%. Given HealthEquity's stronger consensus rating and higher probable upside, equities analysts clearly believe HealthEquity is more favorable than Corpay.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87
Corpay	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

HealthEquity has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Corpay has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Summary

HealthEquity beats Corpay on 9 of the 17 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.17B	$8.18B	$6.18B	$12.25B
Dividend Yield	N/A	2.87%	2.78%	5.22%
P/E Ratio	33.19	22.54	20.66	25.70
Price / Sales	5.25	16.44	529.23	64.52
Price / Cash	16.08	12.66	27.81	36.27
Price / Book	3.31	4.92	9.77	6.74
Net Income	$215.20M	$183.43M	$3.54B	$333.09M
7 Day Performance	N/A	N/A	N/A	0.52%
1 Month Performance	4.73%	7.48%	6.28%	8.98%
1 Year Performance	-9.72%	1.27%	41.80%	42.44%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	4.4513 of 5 stars	$81.65 -3.8%	$111.79 +36.9%	-6.2%	$7.17B	$1.31B	33.19	2,814	Positive News Analyst Downgrade
ITGR Integer	3.0943 of 5 stars	$84.10 +0.1%	$98.29 +16.9%	-25.5%	$2.86B	$1.86B	20.97	11,000
IQV IQVIA	4.443 of 5 stars	$160.64 +1.8%	$226.63 +41.1%	+19.9%	$26.77B	$16.31B	20.44	93,000	Earnings Report Buyback Announcement High Trading Volume
FTAI FTAI Aviation	4.396 of 5 stars	$240.01 +0.0%	$323.63 +34.8%	+152.3%	$24.61B	$2.51B	47.62	40	Analyst Forecast
AER Aercap	4.3638 of 5 stars	$137.89 -2.2%	$163.13 +18.3%	+37.1%	$23.52B	$8.52B	6.04	740	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, IQV, FTAI, AER, and CPAY

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to IQVIA?

Summary

How does HealthEquity compare to FTAI Aviation?

Summary

How does HealthEquity compare to Aercap?

Summary

How does HealthEquity compare to Corpay?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, IQV, FTAI, AER, and CPAY

How does HealthEquity compare to Integer?

Which has preferable earnings & valuation, HQY or ITGR?

Does the media refer more to HQY or ITGR?

Do analysts rate HQY or ITGR?

Is HQY or ITGR more profitable?

Which has more risk & volatility, HQY or ITGR?

Do institutionals & insiders believe in HQY or ITGR?

Summary

How does HealthEquity compare to IQVIA?

Which has higher valuation & earnings, IQV or HQY?

Does the media favor IQV or HQY?

Which has more risk and volatility, IQV or HQY?

Do insiders & institutionals have more ownership in IQV or HQY?

Is IQV or HQY more profitable?

Do analysts prefer IQV or HQY?

Summary

How does HealthEquity compare to FTAI Aviation?

Is FTAI or HQY more profitable?

Which has better earnings & valuation, FTAI or HQY?

Do institutionals & insiders have more ownership in FTAI or HQY?

Do analysts rate FTAI or HQY?

Does the media refer more to FTAI or HQY?

Which has more risk & volatility, FTAI or HQY?

Summary

How does HealthEquity compare to Aercap?

Do analysts prefer AER or HQY?

Does the media prefer AER or HQY?

Do institutionals and insiders have more ownership in AER or HQY?

Which has higher valuation and earnings, AER or HQY?

Which has more risk & volatility, AER or HQY?

Is AER or HQY more profitable?

Summary

How does HealthEquity compare to Corpay?

Is HQY or CPAY more profitable?

Does the media refer more to HQY or CPAY?

Do institutionals & insiders hold more shares of HQY or CPAY?

Which has preferable valuation & earnings, HQY or CPAY?

Do analysts recommend HQY or CPAY?

Which has more volatility and risk, HQY or CPAY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools